dermata therapeutics, llc is a research company based out of 12340 el camino real, san diego, california, united states.
Company profile
Ticker
DRMA
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
DRMA stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
7 May 24
ARS
2023 FY
Annual report to shareholders
26 Mar 24
DEFA14A
Additional proxy soliciting materials
26 Mar 24
DEF 14A
Definitive proxy
26 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results
21 Mar 24
PRE 14A
Preliminary proxy
1 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
12 Jan 24
EFFECT
Notice of effectiveness
18 Dec 23
424B3
Prospectus supplement
15 Dec 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.63 mm | 6.63 mm | 6.63 mm | 6.63 mm | 6.63 mm | 6.63 mm |
Cash burn (monthly) | 602.35 k | 119.61 k | 603.99 k | 627.81 k | 590.54 k | 590.60 k |
Cash used (since last report) | 4.42 mm | 878.34 k | 4.44 mm | 4.61 mm | 4.34 mm | 4.34 mm |
Cash remaining | 2.21 mm | 5.75 mm | 2.20 mm | 2.02 mm | 2.29 mm | 2.29 mm |
Runway (months of cash) | 3.7 | 48.1 | 3.6 | 3.2 | 3.9 | 3.9 |
Institutional ownership, Q2 2023
8.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 9 |
Closed positions | 3 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 111.82 mm |
Total shares | 565.93 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Proehl Gerald T | 183.35 k | $292.00 k |
Intracoastal Capital | 143.94 k | $311.00 k |
Acadian Asset Management | 56.29 k | $92.00 k |
Hale David F | 33.50 k | $53.00 k |
VIRT Virtu Financial | 32.11 k | $53.00 k |
Warberg Asset Management | 30.00 k | $575.00 k |
Armistice Capital | 20.31 k | $508.00 k |
Citadel Advisors | 17.19 k | $28.54 mm |
Susquehanna International | 12.56 k | $20.86 mm |
Boothbay Fund Management | 12.00 k | $19.80 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Jan 24 | Munera Maria E Bedoya-Toro | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6099 | 25,000 | 15.25 k | 25,000 |
4 Jan 24 | Hoose Kyri K. Van | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6099 | 50,000 | 30.50 k | 50,000 |
4 Jan 24 | Andrew Seth Sandler | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6099 | 10,000 | 6.10 k | 10,000 |
4 Jan 24 | Wendell Wierenga | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6099 | 10,000 | 6.10 k | 10,000 |
4 Jan 24 | Hale David F | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6099 | 10,000 | 6.10 k | 10,000 |